GeneMatrix Inc. (KOSDAQ:109820)
South Korea · Delayed Price · Currency is KRW 2,615.00
-5.00 (-0.19%)
At close: Aug 1, 2025, 3:30 PM KST
GeneMatrix Company Description
GeneMatrix Inc. develops diagnostic products for various diseases in the field of molecular diagnostics.
The company offers products for hepatitis B, hepatitis C, cervical cancer, sexually transmitted infections, respiratory infections, and gastrointestinal infections; vaccines for preventing various diseases; and new natural pharmaceutical materials for health enhancement and treatment.
It also provides biochemical diagnostics, such as special chemistry and general chemistry, that includes semi and full auto analyer, and calibrators and controls.
The company was founded in 2000 and is headquartered in Seongnam, South Korea.
GeneMatrix Inc.
| Country | South Korea |
| Founded | 2000 |
| Industry | In Vitro and In Vivo Diagnostic Substances |
| Employees | 31 |
| CEO | Soook Kim |
Contact Details
Address: Korea Bio Park B-Wing Seongnam, 463-400 South Korea | |
| Phone | 82 3 1628 2000 |
| Website | genematrix.net |
Stock Details
| Ticker Symbol | 109820 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Soook Kim | Chief Executive Officer |